Inpatient Characteristics and Outcomes of Venous Thromboembolism Among Children and Adolescents - Top-Institutions - MDSpire

Inpatient Characteristics and Outcomes of Venous Thromboembolism Among Children and Adolescents

  • By

  • Sabrina Friebe

  • Dierk Scheinert

  • Esra Tokur Sonuvar

  • Toralf Kirsten

  • Eva Freisinger

  • June 9, 2026

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins All Children’s Hospital
    Johns Hopkins All Children’s Hospital

    St. Petersburg, Florida

    Key Differentiators

    • Pediatric Hematology
    • Pediatric Thrombosis

  • #2

    Children’s Hospital of Philadelphia
    Children’s Hospital of Philadelphia

    Philadelphia, Pennsylvania

    Key Differentiators

    • Pediatric Hematology
    • Thrombosis

  • #3

    Boston Children’s Hospital
    Boston Children’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Pediatric Hematology
    • Thrombosis

  • #4

    Children's Hospital Los Angeles
    Children's Hospital Los Angeles

    Los Angeles, California

    Key Differentiators

    • Pediatric Hematology
    • Thrombosis

  • #5

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, Massachusetts

    Key Differentiators

    • Pediatric Hematology
    • Oncology

Original Source(s)

Inpatient Characteristics and Outcomes of Venous Thromboembolism Among Children and Adolescents

  • by Sabrina Friebe, Dierk Scheinert, Esra Tokur Sonuvar, Toralf Kirsten, Eva Freisinger

  • June 9, 2026

Related Content

Identification of an NFIA::CBFA2T3 fusion in cerebrospinal fluid confirms the diagnosis of pediatric CNS myeloid sarcoma with erythroid differentiation: a case report and literature review

Computed tomography-derived sarcopenia, enteral nutritional support, and febrile neutropenia burden in children with acute lymphoblastic leukemia: a retrospective cohort study

Treatment Intensity in the Frontline Setting for Transplant-Ineligible Patients With Multiple Myeloma

The management of newly diagnosed transplant-ineligible multiple myeloma remains challenging, in part due to the complexity of treatment decisions for frail patients. Recent subgroup analyses provide insight into whether quadruplet therapy may offer advantages over triplet therapy in this population.